shortagewatch

Home / Cancer and immune system / Selpercatinib

ATC L01EX22 · Other Protein Kinase Inhibitors

Selpercatinib shortage

As of 2 Nov 2026, Selpercatinib has a reported shortage in 1 of the 16 countries we track (Canada), covering 2 products from 1 company.

Countries1/16
Products2packs or presentations
Companies11 listed
Short since22 Jul 20263 months ago
Earliest returnnot givencompany estimate
Main reasonOther
United StatesNo reported shortageCanada2 products shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Canada
RETEVMO (Bottle containing 60 capsules)RETEVMO (Bottle containing 60 capsules)RETEVMO (Bottle containing 60 capsules)RETEVMO (Bottle containing 60 capsules)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Eli Lilly2 LLY

Listed: Eli Lilly LLY · NYSE

Compared with similar medicines

ATC group L01EX · Other Protein Kinase Inhibitors
Sorafenib6/16Sunitinib5/16Nintedanib4/16Pazopanib4/16Pralsetinib1/16Selpercatinib1/16

Affected products

CountryProductCompanySinceExpected backReason
CARETEVMO (Bottle containing 60 capsules) limited anticipatedELI LILLY CANADA INC22 Jul 2026not givenOther
Other (Please describe in comments)
CARETEVMO (Bottle containing 60 capsules) limited anticipatedELI LILLY CANADA INC16 Sep 2026not givenOther
Other (Please describe in comments)

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.